Drew V Tortoriello1, Molina Dayal1, Zeki Beyhan1, Tahsin Yakut2, Levent Keskintepe3,4. 1. Sher Institute for Reproductive Medicine, Las Vegas, NV, USA. 2. Department of Medical Genetics, University of Bursa, Bursa, Turkey. 3. Sher Institute for Reproductive Medicine, Las Vegas, NV, USA. leventk@sherinstitute.com. 4. Department of Medical Genetics, University of Bursa, Bursa, Turkey. leventk@sherinstitute.com.
Abstract
OBJECTIVE: The objective of this study is to determine mosaicism and its effect on blastocysts; abnormal blastocysts determined by molecular testing were sequentially biopsied and retested. MATERIAL AND METHOD: We re-biopsied 37 blastocyst-stage abnormal embryos from eight patients, which were reanalyzed to determine the level of concordance between biopsies and inter-laboratory congruence between reputable commercial PGS laboratories. RESULTS: The main outcome measures were intra-embryo variation between sequential embryo biopsies and inter-laboratory variation between two PGS laboratories. The compatibility between both aCGH and NGS was found to be 11 % (3/27). Importantly, 9/27 (33 %) of embryos originally reported to be aneuploid, upon repeat assessment, were found to be euploid. The concurrence for SNP array and NGS was 50 % (3/6), and 17 % (1/6) of these abnormal embryos tested normal upon re-evaluation with NGS. NGS resulted 41 % (11/27) normal results when 27 of CGH abnormal embryos were retested. Concordance between aCGH and NGS was 4 % (1/27) whereas in three instances, gender discrepancy was observed with NGS when aCGH abnormal embryos were reanalyzed. CONCLUSIONS: The results of these studies reinforce the prevalence of inconsistencies during PGS evaluation of trophectoderm biopsies possibly due to variations in platform sensitivity and heightening concerns over the clinical tractability of such technology in human ARTs..
OBJECTIVE: The objective of this study is to determine mosaicism and its effect on blastocysts; abnormal blastocysts determined by molecular testing were sequentially biopsied and retested. MATERIAL AND METHOD: We re-biopsied 37 blastocyst-stage abnormal embryos from eight patients, which were reanalyzed to determine the level of concordance between biopsies and inter-laboratory congruence between reputable commercial PGS laboratories. RESULTS: The main outcome measures were intra-embryo variation between sequential embryo biopsies and inter-laboratory variation between two PGS laboratories. The compatibility between both aCGH and NGS was found to be 11 % (3/27). Importantly, 9/27 (33 %) of embryos originally reported to be aneuploid, upon repeat assessment, were found to be euploid. The concurrence for SNP array and NGS was 50 % (3/6), and 17 % (1/6) of these abnormal embryos tested normal upon re-evaluation with NGS. NGS resulted 41 % (11/27) normal results when 27 of CGH abnormal embryos were retested. Concordance between aCGH and NGS was 4 % (1/27) whereas in three instances, gender discrepancy was observed with NGS when aCGH abnormal embryos were reanalyzed. CONCLUSIONS: The results of these studies reinforce the prevalence of inconsistencies during PGS evaluation of trophectoderm biopsies possibly due to variations in platform sensitivity and heightening concerns over the clinical tractability of such technology in human ARTs..
Authors: E B Baart; E Martini; I van den Berg; N S Macklon; R-J H Galjaard; B C J M Fauser; D Van Opstal Journal: Hum Reprod Date: 2005-09-09 Impact factor: 6.918
Authors: Laura K Conlin; Brian D Thiel; Carsten G Bonnemann; Livija Medne; Linda M Ernst; Elaine H Zackai; Matthew A Deardorff; Ian D Krantz; Hakon Hakonarson; Nancy B Spinner Journal: Hum Mol Genet Date: 2010-01-06 Impact factor: 6.150
Authors: William B Schoolcraft; Mandy G Katz-Jaffe; John Stevens; Mary Rawlins; Santiago Munne Journal: Fertil Steril Date: 2008-08-09 Impact factor: 7.329
Authors: Antonio Capalbo; Graham Wright; Thomas Elliott; Filippo Maria Ubaldi; Laura Rienzi; Zsolt Peter Nagy Journal: Hum Reprod Date: 2013-06-05 Impact factor: 6.918
Authors: N Gleicher; D F Albertini; D H Barad; H Homer; D Modi; M Murtinger; P Patrizio; R Orvieto; S Takahashi; A Weghofer; S Ziebe; N Noyes Journal: Reprod Biol Endocrinol Date: 2020-05-29 Impact factor: 5.211